A series of adverse reactions occurred in liver cancer patients receiving immunotherapy.
Conditions
Interventions
Small sample screening(Low-risk and high-risk groups):None
Multi-center validation(Low-risk and high-risk groups):None
Sponsors
The Seventh Affiliated Hospital Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.Aged 18 or older; 2.Patients with CNLC ?a or ?b liver cancer; 3.Patients with CNLC ?b liver cancer not suitable for surgical resection or TACE; 4.Patients with liver cancer resistant to or failed TACE; 5.Patients about to receive immune checkpoint inhibitor therapy; 6.No immunodeficiency, such as HIV infection, leukemia, or neutropenia; 7.No history of organ or bone marrow transplantation (autologous bone marrow suppression excluded); 8.No concurrent viral, bacterial, or other pathogen infections; 9.Written informed consent obtained; patient agrees to participate in the study.
Exclusion criteria
Exclusion criteria: None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Adverse effects; | — |
Countries
China
Contacts
Public ContactShuo Fang
The Seventh Affiliated Hospital Sun Yat-sen University
Outcome results
None listed